Home / Alternatives
ArticleAlternativesAsset OwnersSovereign Wealth Funds
Institutional capital looks to unlock growth in Apac healthcare
Private market investments are accelerating drug discovery and capitalising on the burgeoning silver economy in the region.
By AsianInvestor team
16 Sept 2026
300 x 600
Sign in to read on!
- Registered users get 2 free articles in 30 days.
- Subscribers have full unlimited access to AsianInvestor
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
Sign InSign UpSubscription Plan
If you are a senior professional at a large institutional asset owner, such as a sovereign wealth fund or pension fund, please contact subscriptions@asianinvestor.net for further assistance.
Questions? See here for more information on licences and prices, or contact subscriptions@asianinvestor.net
Access in the CMS: Register (wireframe copy, not from the CMS)
#Article#Alternatives#Asset Owners#Sovereign Wealth Funds#Insurers#India#Japan#healthcare
300 x 250
Related Articles
- NZ Super CEO aims to retain status as "best performing SWF"24 Sept 2026
- South Korea set to enhance KIC's role in strengthening AI development23 Sept 2026
- Global allocators are looking at Japan again21 Sept 2026
- Asia’s insurers prioritise liquidity over yield as private market allocations rise17 Sept 2026
300 x 600